BioStock: The five best life science stocks of the first half-year

July 5, 2023
Language flag

PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.

This great acknowledgment comes from Biostock, Scandinavia’s leading digital news and analysis service for the Life Science sector. PHI’s performance has been recognized alongside the life science companies Prolight Diagnostics, Saniona, Lipidor, and Ziccum.

Our team is honored to feature on this top list. And we remain committed to advancing our innovative solutions for non-invasive cell analysis and quality control in regenerative medicine.

Read the full article on biostock.se.

Latest News

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 14 March 2024

On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), held an extraordinary general meeting. The following resolutions were passed at the meeting.
blue-cells_white-bg_banner

Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing

PHI presents a comprehensive opinion piece detailing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all.
Altium_logo

New Distributor Partner Manager at Altium set to enhance global sales for PHI

PHI is conveying the news that its global distributor, Altium ., has appointed a PHI-dedicated distributor partner manager. This strategic step is set to significantly enhance the reach and sales performance of PHI’s HoloMonitor technology on a global scale.
See All News